{
    "elements": [
        {
            "data": {
                "is_heading": 0,
                "text": "Mid & South Essex NHS Foundation Trust"
            },
            "type": "ListItem",
            "sequence_num": 1
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 4,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Ref:"
                    },
                    {
                        "text": "MSEGL-21033"
                    },
                    {
                        "text": "Version:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "23/11/2021"
                    },
                    {
                        "text": "Review date:"
                    },
                    {
                        "text": "22/11/2024"
                    },
                    {
                        "text": "Approved by:"
                    },
                    {
                        "text": "Medicines Assurance Group Chair approval: A.Kabir"
                    },
                    {
                        "text": "08/11/2021"
                    },
                    {
                        "text": "Ratified by:"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "23/11/2021"
                    },
                    {
                        "text": "Author:"
                    },
                    {
                        "text": "Titi Odewumi: Principal Pharmacist Antimicrobials"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Switching intravenous antibiotics to oral therapy in adults guideline"
            },
            "type": "ListItem",
            "sequence_num": 3
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 4
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "Intravenous (IV) to oral switch is the punctual conversion of IV antibiotic therapy to an effective oral dose. Patients may be considered for switching IV to oral therapy once the patient has shown clinical improvement and medically stable."
            },
            "type": "ListItem",
            "sequence_num": 5
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Patients who present with a severe infection and initially require IV therapy can be switched to oral therapy within 48-72 hours, provided that the patient is adequately absorbing oral medication. Studies have shown that there are a number of advantages to support the IV to oral switch."
            },
            "type": "ListItem",
            "sequence_num": 6
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reduces risk of hospital acquired bacteraemia and infected IV lines"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reduces discomfort for patients and improved mobility"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reduces hospital stay and facilitates early discharge from the hospital."
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient is more likely to receive antibiotics at the correct time"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reduced risk of administration errors"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reduced pharmaceutical and consumables costs in medical and nursing time"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reduced use of venous access and incidence of thrombophlebitis."
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "Furthermore, studies found that the early switch of IV to oral antibiotics results in equal clinical efficacy compare to treatment with parenteral antibiotics for the full course."
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "The acronym COMS (see below for details) provides advice whether a patient is suitable to be converted to oral therapy."
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.1,
                "text": "The guideline is applicable to all antimicrobial prescribers in the Trust."
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "It  aims  to  provide  guidance  on  the  appropriate  switching  of  intravenous  to  oral antibiotics, and to facilitate prudent prescribing practices; thereby reducing the rate of cannula associated infections whilst enabling early hospital discharge."
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "When to Switch?"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "Considerations for the early switch to oral therapy COMS.Patient should be reviewed at 48-72 hours"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 1,
                "text": "C Clinical improvement observed"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "text": "O Oral route not compromised (vomiting, malabsorption disorder, NBM, swallowing difficulties, unconscious, severe diarrhoea) NB: if enteral feeding then please consult your pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 1,
                "text": "M Markers showing a trend towards normal NEWS2 score of zero OR"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 1,
                "text": "The following infection markers:"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Apyrexial: Temp >36oC and oCfor at least 24 hours"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 1,
                "text": "BP stable"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Plus NO more than one of:"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Heart rate >90 beats/min"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Respiratory rate >20 breaths/min"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "WCC < 4 or > 12 (WCC should show a trend towards normal; absence of such should not hinder switch if all other criteria met and patient is not neutropenic)."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 1,
                "text": "S Specific indication/deep-seated infection. (Refer to table 1)"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "High risk/deep-seated infections"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Certain deep seated/high risk infections require persistent IV therapy. This assures that sufficient drug levels are attained at the site of infection thereby optimising response and preventing relapse."
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "Discuss with microbiology before switching patients with high risk/ deep seated infection to oral therapy"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "Table 1 Infections requiring over 72hrs of IV Antibiotics"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "type": "table",
            "sequence_num": 36,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Deep seated infections that may require an initial two weeks of IV therapy"
                    },
                    {
                        "text": "High risk infections requiring prolonged IV therapy."
                    },
                    {
                        "text": "Liver abscess Osteomyelitis Septic arthritis. Cavitating pneumonia"
                    },
                    {
                        "text": "Bacteraemia caused by Staphylococcus aureus OR Pseudomonas aeruginosa. Severe necrotising soft tissue infections Severe infections during chemotherapy related neutropenia Moderate to Severe Cellulitis Infected implants/prosthesis Meningitis/encephalitis Intracranial abscesses Mediastinitis Endocarditis Exacerbation of cystic fibrosis/bronchiectasis Inadequately drained abscesses Empyema"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "Early switching could take place earlier than 48 hours in some circumstances if the other conditions are met. For example, where the oral formulation of the drug is bioequivalent to the intravenous form e.g. the quinolones (ciprofloxacin and levofloxacin), metronidazole, chloramphenicol, sodium fusidate, linezolid."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "In-line with antimicrobial stewardship expectations, ward based pharmacists and pharmacy technicians should always check if an IV antibiotic is suitable for an oral switch, and alert the prescriber as such."
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Table 2: Intravenous to oral antibiotic conversion"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "type": "table",
            "sequence_num": 40,
            "data": {
                "num_rows": 12,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Intravenous Dose"
                    },
                    {
                        "text": "Oral Dose"
                    },
                    {
                        "text": "Amoxicillin 500mg \u2013 1g TDS"
                    },
                    {
                        "text": "Amoxicillin 500mg TDS"
                    },
                    {
                        "text": "Benzyl penicillin 1.2g QDS"
                    },
                    {
                        "text": "Amoxicillin 500-1g TDS"
                    },
                    {
                        "text": "Clarithromycin 500mg BD"
                    },
                    {
                        "text": "Clarithromycin 500mg BD"
                    },
                    {
                        "text": "Co-amoxiclav 1.2g TDS"
                    },
                    {
                        "text": "Co-amoxiclav 625mg TDS"
                    },
                    {
                        "text": "Clindamycin 600mg-1.2gm BD- QDS"
                    },
                    {
                        "text": "Clindamycin 450mg QDS"
                    },
                    {
                        "text": "Ciprofloxacin 400mg BD"
                    },
                    {
                        "text": "Ciprofloxacin 500mg BD"
                    },
                    {
                        "text": "Co-trimoxazole 960mg BD"
                    },
                    {
                        "text": "Co-trimoxazole 960mg BD"
                    },
                    {
                        "text": "Flucloxacillin 1-2g QDS"
                    },
                    {
                        "text": "Flucloxacillin 500mg-1g QDS"
                    },
                    {
                        "text": "Metronidazole 500mg TDS"
                    },
                    {
                        "text": "Metronidazole 400mg TDS"
                    },
                    {
                        "text": "Levofloxacin 500mg OD-BD"
                    },
                    {
                        "text": "Levofloxacin 500mg OD-BD"
                    },
                    {
                        "text": "Tazocin, Vancomycin, Meropenem, Gentamicin, Teicoplanin, Ceftriaxone , ceftazidime"
                    },
                    {
                        "text": "Follow the MSE Trust Guideline specific indication tables for oral antibiotic recommendations or contact microbiology"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.7,
                "text": "Above are standard doses; dose adjustment maybe required in renal or hepatic impairments"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "IV to Oral switch Flow Chart"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "type": "image",
            "sequence_num": 43,
            "data": {
                "url": "MSEGL-21033 Switching intravenous antibiotics to oral therapy in adults guideline.001.png"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Does intravenous therapy need to continue?"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Considerations for IV to oral switch COMS"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 1,
                "text": "C  Clinical improvement"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 1,
                "text": "O  Oral route not compromised by"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "- Vomiting"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "- NBM"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "- Unconscious"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "- Mechanical swallowing disorder"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "- Malabsorptive disorder"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NB: if NG/PEG feeding then please consult your pharmacist Suitable oral antibiotic option available"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 1,
                "text": "M  Markers showing a trend towards normal"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Pyrexia: Temp >36oC and oCfor at least 24 hours"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "BP stable"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Plus NO more than one of"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Heart rate >90 beats/min"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Respiratory rate >20 breaths/min"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "WCC <4 or >12 (WCC should show a trend towards normal; absence of such should not hinder switch if all other criteria met and patient is not neutropenic.)"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 1,
                "text": "S  Specific indication/deep-seated infection (do not switch in these conditions"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 1,
                "text": "YES  NO"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Switch to oral therapy*"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 1,
                "text": "IV  Oral"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Amoxicillin  Amoxicillin"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Flucloxacillin  Flucloxacillin"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Benzylpenicillin   Amoxicillin"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Clarithromycin   Clarithromycin  Continue with IV  Co-amoxiclav   Co-amoxiclav"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Fluconazole  Fluconazole"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clindamycin  Clindamycin"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Metronidazole   Metronidazole Review again after"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Tazocin, Vancomycin"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Meropenem, Gentamicin Seek advice from 24 hours  Teicoplanin Microbiology"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Monitor Patient's Progress"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Public Health England. Antimicrobial stewardship: start smart then focus (2015)"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Department of Health. Saving lives: reducing infection, delivering clean and safe care: Antimicrobial prescribing, a summary of best practice. London: Department of Health. 2007"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Sevinc F, Prins JM, Koopmans RP et al. Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. JAntimicrob Chemother 1999; 43:601-6."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "McLaughlin C et al. Pharmacy implemented guidelines on switching from intravenous to oral antibiotics: an intervention study. Q J Med 2005; 98:745-752 http://qjmed.oxfordjournals.org/content/98/10/745"
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Sze WT, and Kong MC. Impact of printed antimicrobial stewardship recommendations on early intravenous to oral antibiotics switch practice in district hospitals. Pharmacy Practice 2018 April-June; 16 (2): 855"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Royal College of Physicians. National Early Warning Score (NEWS) 2: Standardising the assessment of acute-illness severity in the NHS. Updated report of a working party. London: RCP, 2017"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Switching intravenous antibiotics to oral therapy in adults guideline/ MSEGL-21033 /1.0"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 83
        }
    ]
}